Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
MetLifeMET -0.35%77 12-1 Month Momentum % is 17.32% as of Aug. 26, 2026. GuruFocus rates MET with a GF Score™ of 77/100 and a GF Value™ of $92.89 (Fairly Valued). The stock has 8 warning signs investors should review. Among 583 Insurance companies, MetLife ranks better than 65.35% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-08-26), MetLife's 12-1 Month Momentum % is 17.32%.
The industry rank for MetLife's 12-1 Month Momentum % or its related term are showing as below:
MET's 12-1 Month Momentum % is ranked better than 65.35% of 583
companies
in the Insurance industry
Industry Median: 4.62
vs MET: 17.32
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
MetLife 12-1 Month Momentum % Related Terms
MET vs AFL, PRU, UNM: 12-1 Month Momentum % Comparison
For the Insurance - Life subindustry, MetLife's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MetLife 12-1 Month Momentum % vs Insurance Industry
For the Insurance industry and Financial Services sector, MetLife's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where MetLife's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MetLife (MET) has a 12-1 Month Momentum % of 17.32% as of Aug. 26, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on MetLife and its competitors. According to the industry distribution chart, MetLife ranks #202 out of 583 companies in the Insurance industry, placing it in the top 34.6%.
Is MetLife's 12-1 Month Momentum % too high?
MetLife's current 12-1 Month Momentum % is 17.32%. The Insurance industry median 12-1 Month Momentum % is 4.62. MetLife's value of 17.32% is 274.9% above this industry median. Based on the distribution chart, MetLife ranks #202 out of 583 companies in the Insurance industry, which is above the industry midpoint. Overall, MetLife has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does MetLife's 12-1 Month Momentum % compare to AFL and PRU?
According to the Insurance industry distribution chart, MetLife ranks #202 out of 583 companies for 12-1 Month Momentum %. This puts MetLife in the upper half of its industry. The industry median 12-1 Month Momentum % is 4.62. MetLife's value of 17.32% is 274.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for an Insurance company?
The median 12-1 Month Momentum % among Insurance companies is 4.62, based on 583 companies in the industry. Companies in the top quartile (top 25%) have a 12-1 Month Momentum % significantly above this median, while those in the bottom quartile fall well below. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MetLife's current 12-1 Month Momentum % of 17.32% is 274.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on MetLife and its competitors. For the Insurance industry, the median 12-1 Month Momentum % is 4.62 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MetLife's current 12-1 Month Momentum % is 17.32%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MetLife stock overvalued right now?
Based on GuruFocus' analysis, MetLife (MET) is currently considered Fairly Valued. The stock's GF Value™ is $92.89, compared to a current price of $95.87 — trading 3.2% above its estimated fair value. The current 12-1 Month Momentum % is 17.32% and 274.9% above the Insurance industry median of 4.62. MetLife's overall GF Score™ is 77/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For MetLife (MET), the current 12-1 Month Momentum % is 17.32% as of Aug. 26, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MetLife (MET) Overvalued in 2026?
Based on GuruFocus' analysis, MetLife stock appears to be overvalued.
The current stock price of $95.87 is trading 3.2% above its estimated GF Value™ of $92.89.
GuruFocus considers MetLife to be Fairly Valued.
Key valuation signals for MET:
12-1 Month Momentum %: 17.32%
GF Value™: $92.89 vs. price of $95.87 (3.2% above fair value)
Industry Position: 274.9% above the Insurance median (#202 of 583)
No single metric tells the full story. See the MET stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
77GF Score
Get the complete analysis for MET
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MET has been successfully added to your 
